全文获取类型
收费全文 | 587篇 |
免费 | 40篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 34篇 |
妇产科学 | 4篇 |
基础医学 | 81篇 |
口腔科学 | 8篇 |
临床医学 | 40篇 |
内科学 | 181篇 |
皮肤病学 | 7篇 |
神经病学 | 85篇 |
特种医学 | 5篇 |
外科学 | 58篇 |
综合类 | 1篇 |
预防医学 | 28篇 |
眼科学 | 7篇 |
药学 | 28篇 |
中国医学 | 3篇 |
肿瘤学 | 50篇 |
出版年
2024年 | 1篇 |
2023年 | 4篇 |
2022年 | 4篇 |
2021年 | 16篇 |
2020年 | 5篇 |
2019年 | 20篇 |
2018年 | 23篇 |
2017年 | 8篇 |
2016年 | 11篇 |
2015年 | 17篇 |
2014年 | 22篇 |
2013年 | 21篇 |
2012年 | 27篇 |
2011年 | 48篇 |
2010年 | 22篇 |
2009年 | 28篇 |
2008年 | 24篇 |
2007年 | 34篇 |
2006年 | 25篇 |
2005年 | 28篇 |
2004年 | 41篇 |
2003年 | 26篇 |
2002年 | 25篇 |
2001年 | 16篇 |
2000年 | 25篇 |
1999年 | 24篇 |
1998年 | 8篇 |
1997年 | 7篇 |
1996年 | 3篇 |
1995年 | 2篇 |
1994年 | 4篇 |
1993年 | 4篇 |
1992年 | 9篇 |
1991年 | 5篇 |
1990年 | 10篇 |
1989年 | 6篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1977年 | 1篇 |
1973年 | 3篇 |
1971年 | 1篇 |
1969年 | 2篇 |
1968年 | 4篇 |
1947年 | 1篇 |
排序方式: 共有627条查询结果,搜索用时 31 毫秒
1.
2.
3.
J M González Santos J L Vallejo J C Sevilla K Abukassem P Garrido E Bastida M Riesgo R Fortuny R Arcas 《Revista espa?ola de cardiología》1991,44(10):639-647
We present here the clinical results with a second-generation porcine bioprosthesis, the Carpentier-Edwards supra-annular valve (CESA). Two-hundred and twenty-two CESA bioprostheses were implanted in 189 patients during a four-year period (from 1984 to 1987), either as an isolated procedure or associated to mitral or tricuspid repair. The mid-term clinical results have been evaluated after a mean follow-up of 3.4 years, being 96% complete. There were 16 in-hospital deaths (8.4%) and 6 late, potentially valve-related, cardiac deaths (1.1% patients/year). Overall, 86.7 +/- 2% of the patients were free from cardiac death at 6 years (95.1 +/- 2% of the patients surviving the operative period). Linearized rates of valve related complications were the following: 1.4% patients/year for thromboembolism (including valve thrombosis), 0.5% patients/year for treatment-related hemorrhage and 0.7% patients/year for endocarditis. We did not found any case of either intrinsic or extrinsic valve failure, unrelated to infection of thrombosis. Two patients were reoperated, one because of valve thrombosis and the other due to prosthetic valve endocarditis (reoperation rate of 0.3% patients/year). When lethal and nonlethal valve-related complications (including in-hospital deaths) were considered all together, 75.8 +/- 8.4% of the patients remained alive and free of morbid events at 6 years. When patients were grouped according to the valve replaced (aortic, mitral and multiple), best results were found with patients submitted to isolated aortic valve replacement. We conclude that the CESA bioprosthesis has an excellent mid-term clinical performance. However, longer follow-up is necessary to know if improvement in valve design and manufacturing results in increased valve durability. 相似文献
4.
Sevilla C Moatti JP Julian-Reynier C Eisinger F Stoppa-Lyonnet D Bressac-de Paillerets B Sobol H 《European journal of human genetics : EJHG》2002,10(10):599-606
Breast carcinoma is the most common type of cancer affecting women in the Western world. The hereditary forms, which amount from 5 to 10% of all the cases of breast cancer, mainly involve BRCA1 or BRCA2 mutations. Due to the diagnostic strategy used by the patent owner, Direct DNA sequencing (DS) may become the only BRCA1/2 test procedure available, although there exist several alternative strategies. A cost-effectiveness study was carried out using BRCA1 testing as a model. The main techniques available for performing mutation searches were assessed: DS, denaturing high performance liquid chromatography (DHPLC), single-strand conformation polymorphism (SSCP), denaturing gradient gel electrophoresis (DGGE), heteroduplex analysis (HA), fluorescent assisted mismatch analysis (FAMA) and the protein truncation test (PTT). Twenty strategies involving the use of one or more techniques were then devised for performing the complete genetic analysis. DS was adopted as the 'gold standard' for effectiveness. All the strategies except for DS involved a two-step procedure. The first step consisted of pre-screening the 22 coding exons of BRCA1. The second step consisted of performing DS only on the variations detected in the coding sequence. The cost of the strategies tested, including a pre-screening stage, turned out to be 30 to 90% lower than that of DS, whatever annual use was made of the equipment. The most cost-effective strategy, ie, that corresponding to the lowest cost per mutation detected, was found to be a combination between PTT on exon 11 (60% of the coding sequence) and HA on the remaining 21 exons (PTT(11)+ HA(21)). However, since a high false negative rate is associated with this strategy, at least four other strategies are worth mentioning: PTT(11)+ DHPLC(21), DHPLC alone, FAMA(11)+ DHPLC(21) and FAMA alone. Our results on genetic testing for breast cancer show that DS is not the most cost-effective method available. The monopolist approach of the firm which owns the patents on the BRCA1/2 genes, may, therefore limit the use of the most cost-effective strategies. 相似文献
5.
De Castro M Cruz-Martínez A Vílchez JJ Sevilla T Pineda M Berciano J Palau F 《Journal of the peripheral nervous system : JPNS》1999,4(1):58-62
The aim of this study was to determine phenotypie characteristics of patients with early onset cerebellar ataxia (EOCA) with preserved tendon reflexes. The series comprises 25 patients, representing 10% of all ataxic patients who have been genetically studied in our laboratory since 1990. There were 11 males and 14 females. Fourteen patients were homozygous for the GAA expansion on chromosome 9q13 (group 1) and therefore a diagnosis of Friedreich's ataxia with retained reflexes (FARR) was given. The remaining 11 patients had two normal non-expanded alleles (group 2) and a working diagnosis of EOCA with retained reflexes (EOCARR) was established. Mean ages of onset were 13.7 +/- 5.9 years (3-25) for group 1 and 10.3 +/- 7.3 for group 2; the difference was not significant. Frequencies of symptoms and signs were also comparable for both groups the only significant differences being the higher frequency of nystagmus, cardiomyopathy and sensory neuropathy in group 1 patients. There was a tendency for FARR patients to have higher frequencies of hypopallesthesia in the lower limbs and skeletal deformities. In none of the cases diabetes mellitus was observed. We conclude that differentiation of FARR and EOCARR may be suspected by classical clinical and electrophysiological data and confirmed by analysis of the GAA repeat. 相似文献
6.
7.
8.
M. Reyes‐Sevilla R. H. Kuijs A. Werner C. J. Kleverlaan F. Lobbezoo 《Journal of oral rehabilitation》2018,45(7):539-544
Tooth wear in bruxing patients often results in a need for treatment with composite restorations. In some cases, bruxing patients receive an occlusal splint as a protective means as well. However, the wear between these opposing materials has not been investigated yet. The aim of this in vitro study was to assess the wear of different splint materials against resin composite materials. A two‐body wear test was conducted using the ACTA wear machine. The materials selected for this study were three composites used for direct restorations (Filtek Z250, CLEARFIL AP‐X, and Filtek Supreme XT) and four occlusal splints materials, viz. a polyamide resin (ThermoSens) an conventional (hand‐processed), milled and printed polymethylmethacrylate (PMMA). As antagonistic materials, stainless steel, Filtek Supreme XT and CLEARFIL AP‐X were used. The wear rate of the seven materials was determined after 200 000 cycles, using a profilometry. The rates were analysed using two‐way ANOVA and post hoc Tukey's tests. The wear rates were significantly higher for the conventional and milled PMMA materials than for all other materials (P < .001). The wear rates of printed PMMA and the polyamide resin were comparable to composite wear rates. The antagonist materials have minor or no influence on the amount of wear of the various splint materials (P < .001). In conclusion, different splint materials yielded different wear rates for all antagonist materials tested. Keeping in mind that this study is an experimental in vitro study, this finding enables practitioners to choose the splint material necessary according to their patients’ needs. 相似文献
9.